Outstanding Science Alumni Awards 2005
BScPharm 1977
Co-founder/Executive Chairman, ICON Clinical PLC

John CLIMAX, one of ICON's two co-founders, has served as a Director and Chief Executive Officer of ICON and its subsidiaries since June 1990. In November 2002, he was appointed Executive Chairman. He has over 25 years of experience in the contract research industry in both Europe and the United States.
John received his primary degree in pharmacy in 1977 from the University of Singapore, his masters in applied pharmacology in 1979 from the University of Wales and his PhD in pharmacology from the National University of Ireland in 1982. He has authored a significant number of papers and presentations. In 2005 he was appointed adjunct professor at the Royal College of Surgeons (Ireland).
"The courage to follow your passion wherever in the world it takes you. The strength to recognise failure as another opportunity. The wisdom to view successes as possibilities in pushing the boundaries."
ICON Clinical PLC

ICON today is the forth largest global drug development organization which manages clinical trials in all major therapeutic areas, including CNS, cardiology, dermatology, endocrinology, gastroenterology, infectious diseases, oncology, pain management, paediatrics, respiratory, and urology. ICON was listed in the US on NASDAQ in 1998.

ICON reports 10% increase in net revenues and EPS of 42 cents. (NASDAQ:ICLR)
Dublin, Ireland, September 27, 2005 - ICON plc (NASDAQ: ICLR), a global contract clinical research organisation, which has approximately 2,800 employees providing services to the pharmaceutical, biotech and medical device industries from 37 locations in 23 countries worldwide, reported the financial results for its fourth quarter ended August 31, 2005.